Mangalam Drug Chem Share Price

Mangalam Drug Chem Share Price

NSE: MANGALAM
|
Pharmaceuticals
|
S Cap
₹ 32.95
+₹0.71 (2.20%)
1D
Last updated 23 Sep, 2026, 10:36 IST

Mangalam Drug Chem Share Price Today

As of 23 Sep 2026, Mangalam Drug Chem share price is ₹32.95. The stock opened at ₹32.95, compared to its previous close of ₹32.24. During today's trading session, Mangalam Drug Chem share price moved in the range of ₹32.59 to ₹34.30, with an average price of ₹33.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹22.80 and a high of ₹77.60. On the performance front, Mangalam Drug Chem share price has increased by 6.75% over the last six months and is down 57.04% on a year-on-year basis.

₹32.59
2.20% up today
₹34.30
1D LOW
1D HIGH

Mangalam Drug Chem Returns Calculator

Circuit
L
H
₹29.02
₹35.46
52-week
L
H
₹22.80
₹77.60

About Mangalam Drug Chem

Mangalam Drug Chem Share Price
ISIN
INE584F01014
Sector Market Cap
₹ 52.17 Cr

Mangalam Drugs and Organics Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs) and intermediates. Under the Company's Fight Malaria Program, it supplies anti-malaria APIs worldwide. Its products include API, intermediates and specialty chemicals. Its API products include acyclovir, amodiaquine, artemether, artesunate, atazanavir sulfate, bisoprolol fumarate, chloroquine phosphate, furosemide and dolutegravir sodium. The Company's intermediates products include 4,6-Dichloro-5-Methoxy Pyrimidine; 4,7- dichloroquinoline; ortho phenoxy methane sulfonanilide; tenofovir alafenamide base, and tenofovir disoproxil base. Its specialty chemical products include L (+)-menthol; 2,3-dihydrophthalazine-1,4-dione or phthalazine-1,4-dione, and 4-cynoethyl-2-methyl phenol. Its pipeline APIs (under development) include Ganaplacide (IH), Tafenoquine Succinate (IH) and Pretomanid (IH). Its pipeline APIs (developed for research and development) is Bictegravir Na (IH).

Mangalam Drug Chem Financial Highlights

  • Revenue: Mangalam Drug Chem reported revenue of ₹232.89 crore in FY26 vs ₹318.74 crore in FY25. It showed a decrease of 26.93% on a yearly basis.
  • Operating Profit: Mangalam Drug Chem reported an operating loss of ₹48.57 crore in FY26 vs ₹4.79 crore in FY25. It showed a decrease of 1,113.99% on a year-on-year basis.
  • Net Profit: Mangalam Drug Chem reported a net loss of ₹44.40 crore in FY26 vs ₹6.72 crore in FY25. It showed a decrease of 760.71% on a yearly basis.

Mangalam Drug Chem Quarterly Result Highlights

  • Mangalam Drug Chem reported revenue of ₹57.23 crore in Jun 2026, compared with ₹67.38 crore in Mar 2026, representing a decrease of 15.06% on a quarter-on-quarter (QoQ) basis.
  • Mangalam Drug Chem reported an operating loss of ₹6.75 crore in Jun 2026, compared with ₹13.27 crore in Mar 2026, representing an increase of 49.13% on a quarter-on-quarter (QoQ) basis.
  • Mangalam Drug Chem reported a loss of ₹7.64 crore in Jun 2026, compared with ₹13.42 crore in Mar 2026, reflecting an increase of 43.07% on a QoQ basis.
  • The earnings per share (EPS) of Mangalam Drug Chem stood at ₹4.25 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
35.65%
FII
0.11%
Other DII
0.00%
Retail and other
64.24%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.11%
Dec 20250.13%
Mar 20260.32%
Jun 20260.11%
Mkt Cap Cr
51.25
P/E
-1.34
P/B
0.53
ROE
-43.08%
D/E
1.02
ROCE
-15.40%
Div. Yield
0.00%
EPS(TTM)
-27.68
Turnover
0.75
EV/EBITDA
-18.09
Net Margin
0.00%
Op. Margin
0.00%
ROA
-12.14%
Quick Ratio
0.00
Curr. Ratio
1.68
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Mangalam Drugs outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Mangalam Drugs appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Mangalam Drugs earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,48,196.0036.515.2913.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,50,390.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,967.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,888.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,00,329.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma98,803.9026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Mangalam Drug Chem Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Revenue₹318.23₹368.59
Other Income₹0.50₹0.10
Total Revenue₹318.73₹368.69
Total Expenses₹313.95₹379.77
Profit Before Tax₹4.79-₹11.07
Tax-₹1.93-₹2.00
Profit After Tax₹6.72-₹9.07
EPS - Basic₹4.25-₹5.73
EPS - Diluted₹4.25-₹5.73

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Profit before tax₹4.79₹3.97
Income before WC changes₹35.38₹17.92
Change in Assets-₹21.30₹29.86
Change in Liabilities₹28.59-₹43.77
Change in WC₹7.29-₹13.91
Cash flow from Operations₹42.59₹3.91
Cash flow from Investing-₹19.47-₹11.83
Cash flow from Financing-₹21.71₹5.23
Total Cash Flow₹1.41-₹2.69
Cash (Start of the year)₹1.18₹3.87
Cash (End of the year)₹2.59₹1.18

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Non-Current Assets₹167.44₹157.70
Current Assets₹198.98₹176.00
Total Assets₹366.42₹333.70
Current Liabilities₹191.60₹164.06
Net Current Asset₹7.38₹11.94
Non-Current Liabilities₹25.84₹33.85
Equity Capital₹148.98₹135.79
Total Equity & Liabilities₹366.42₹333.70

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹318.23₹368.59₹372.25₹451.07
Other Income₹0.50₹0.10₹0.44₹0.09
Total Revenue₹318.73₹368.69₹372.69₹451.16
Total Expenses₹313.74₹379.75₹370.47₹423.42
Profit Before Tax₹4.99-₹11.06₹2.21₹27.73
Tax-₹1.93-₹2.01₹0.94₹8.08
Profit After Tax₹6.92-₹9.05₹1.27₹19.66
EPS - Basic₹4.37-₹5.72₹0.80₹12.42
EPS - Diluted₹4.37-₹5.72₹0.80₹12.42

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹4.99-₹11.06₹2.21₹27.73
Income before WC changes₹35.36₹16.75₹26.34₹50.11
Change in Assets₹2.64₹4.02-₹19.29-₹46.67
Change in Liabilities₹4.84-₹8.42₹31.01₹31.08
Change in WC₹7.49-₹4.39₹11.72-₹15.59
Cash flow from Operations₹42.76₹12.17₹38.08₹25.71
Cash flow from Investing-₹19.47-₹17.90-₹22.17-₹27.33
Cash flow from Financing-₹21.71₹5.70-₹16.82₹2.98
Total Cash Flow₹1.57-₹0.04-₹0.91₹1.36
Cash (Start of the year)₹1.00₹1.04₹1.95₹0.58
Cash (End of the year)₹2.57₹1.00₹1.04₹1.95

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹160.25₹157.36₹154.72₹143.39
Current Assets₹198.99₹199.78₹203.26₹185.03
Total Assets₹359.24₹357.14₹357.98₹328.43
Current Liabilities₹184.74₹180.95₹163.71₹130.11
Net Current Asset₹14.25₹18.83₹39.55₹54.92
Non-Current Liabilities₹25.84₹33.85₹42.32₹47.75
Equity Capital₹148.66₹142.35₹151.96₹150.56
Total Equity & Liabilities₹359.24₹357.14₹357.98₹328.43
* All values are in INR Crore
Qty
Bid
6
32.95
17
32.92
175
32.9
34
32.69
310
32.68
Ask
Qty
33.06
100
33.1
6
33.14
742
33.29
605
33.3
1028
Bid Total: 542
Ask Total: 2481
Buy orders: 18%
Sell orders: 82%
Bearish
1
Neutral
5
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
53.56
Neutral
ATR (14)
2.43
Neutral
STOCH(9,6)
38.3
Neutral
STOCH RSI (14)
14.26
Bullish
ADX(9)
30.52
Bearish
UO(9)
45.3
Neutral
ROC(12)
6.4
Bullish
WillR(14)
-61.7
Neutral
Period
Simple value
Exponential vaue
5D
32.62
32.75
10D
32.9
32.55
20D
31.96
31.72
50D
29.25
30.26
100D
29.18
30.17
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep1L
18 Sep1L
17 Sep0L
16 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Mangalam Drug Chem Share Price
Mangalam Drug Chem
Pharmaceuticals
Add Stock
Add Another

Mangalam Drug Chem Share Price FAQs

Mangalam Drug Chem share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837